The CEO of Merck on race, leadership, and high drug prices

Harvard Business Review

19 February 2018 - Kenneth Frazier, the CEO of MSD, discusses his upbringing and how it influences his leadership as chief executive. 

He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. 

Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.

Read Harvard Business Review article


Michael Wonder

Posted by:

Michael Wonder